Innovative pectin-based synbiotic microcapsules enhance probiotic stability and survivability in acidic beverages. Utilizing Bacillus spores, these microcapsules release probiotics in the intestines, promising improved health benefits when integrated into food products.
Our innovative solution involves the development of pectin-based synbiotic microcapsules designed to enhance the stability and survivability of probiotic Bacillus spores in acidic beverages. This advanced encapsulation technique utilizes the prebiotic properties of pectin, enhanced by calcium ions, to ensure that the probiotics are stable in the stomach and release effectively in the intestines. This novel approach promises significant health benefits when integrated into various food products, particularly beverages.
Key features:
The technology is currently at TRL 3, indicating experimental proof of concept. Ongoing research focuses on optimizing encapsulation methods and assessing probiotic stability under simulated digestive conditions to advance the development and commercial application of this technology.
The University of Georgia is a comprehensive public land‑grant research university serving a large student body across multiple campuses, known for applied scholarship and community partnership. Industry partners access core facilities and pilot‑scale capabilities—including the Food Product Innovation and Commercialization Center—for prototyping, scale‑up, and product validation. A downtown Innovation District and a statewide Cooperative Extension network link campus expertise to companies across Georgia, while proximity to Atlanta’s corporate and logistics hubs lowers barriers to engagement. Research is supported by competitive federal funding from agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office provides IP services, licensing, startup support, and incubator space to accelerate commercialization.